Encompass Health (AMEX:EHC) had its price objective boosted by Credit Suisse Group from $58.00 to $61.00 in a research note issued on Tuesday. The brokerage currently has an “outperform” rating on the stock. Credit Suisse Group’s target price would indicate a potential upside of 14.53% from the stock’s current price.
EHC has been the topic of several other research reports. SunTrust Banks set a $58.00 price target on Encompass Health and gave the company a “buy” rating in a research note on Thursday, December 21st. Zacks Investment Research upgraded Encompass Health from a “hold” rating to a “buy” rating and set a $60.00 price objective for the company in a report on Tuesday, January 30th. Royal Bank of Canada restated a “buy” rating on shares of Encompass Health in a report on Wednesday, November 15th. Wells Fargo & Co started coverage on Encompass Health in a report on Tuesday, January 30th. They issued a “market perform” rating and a $56.00 price objective for the company. Finally, William Blair restated an “outperform” rating on shares of Encompass Health in a report on Tuesday, November 21st. Two investment analysts have rated the stock with a sell rating, four have issued a hold rating and eight have given a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus target price of $56.20.
Shares of Encompass Health (EHC) opened at $53.26 on Tuesday. Encompass Health has a 12 month low of $40.86 and a 12 month high of $56.13. The stock has a market capitalization of $5,240.00, a PE ratio of 19.65, a price-to-earnings-growth ratio of 1.70 and a beta of 0.49. The company has a quick ratio of 1.34, a current ratio of 1.34 and a debt-to-equity ratio of 1.89.
Hedge funds and other institutional investors have recently made changes to their positions in the company. FNY Managed Accounts LLC bought a new position in shares of Encompass Health in the 4th quarter valued at about $125,000. Cerebellum GP LLC bought a new position in Encompass Health during the fourth quarter worth about $129,000. Heartland Advisors Inc. bought a new position in Encompass Health during the fourth quarter worth about $237,000. Zeke Capital Advisors LLC bought a new position in Encompass Health during the fourth quarter worth about $238,000. Finally, S. R. Schill & Associates bought a new position in Encompass Health during the fourth quarter worth about $401,000. Institutional investors own 93.18% of the company’s stock.
ILLEGAL ACTIVITY WARNING: This news story was first reported by Ticker Report and is owned by of Ticker Report. If you are reading this news story on another website, it was stolen and reposted in violation of international trademark & copyright laws. The original version of this news story can be read at https://www.tickerreport.com/banking-finance/3229278/encompass-health-ehc-pt-raised-to-61-00.html.
About Encompass Health
Encompass Health Corporation, formerly HealthSouth Corporation, is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies.
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.